A recent study has revealed that individuals who have successfully recovered from the novel coronavirus will have sustained antibody protection from the illness, which may last for upwards of eleven months after the initial infection. This study’s outcomes were recently released by the Washington University School of Medicine, which is based in St. Louis, Missouri.
Moreover, university researchers also determined that consistent exposure to COVID may enhance antibody protection without incurring the risk of suffering serious illness. Per various scientists, 99.4 percent of coronavirus cases result in a mild form of the illness, while 98 percent of all infected individuals experience a full recovery from the COVID virus.
Findings from @WUSTLmed and @WUDeptMedicine researchers suggest that mild cases of COVID-19 leave those infected with lasting antibody protection and that repeated bouts of illness are likely to be uncommon. @WashUID https://t.co/f5n4U646yN via @wustlmed
— WUSM Department of Medicine (@WUDeptMedicine) May 25, 2021
Scientists have not yet determined how long immunity will persist with the coronavirus vaccine. Currently, other studies are taking place to assess whether or not the COVID vaccine will induce the creation of long-lived antibody cells.